• One in Two podcast - The basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation

  • Jun 9 2023
  • Duración: 1 h y 12 m
  • Podcast

One in Two podcast - The basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, we speak to Dr Colin Lindsay, Clinical Senior Lecturer at The Christie and The University of Manchester about the basic biology of lung cancer, focusing on:

    • The high incidence of lung cancer here in Manchester
    • The differences between non-small cell and small-cell lung cancer
    • Oncogenic drivers in lung cancer such as the KRAS mutation
    • His work on the drug sotorasib which targets KRAS mutant cancer and has now been approved by the FDA and for use in the UK by NICE

    Colin Lindsay's research profile

    EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells

    KRAS: Reasons for optimism in lung cancer

    On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma

    Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

    Molecular characterization of primary and secondary resistance to RET inhibitors in patients

    with advanced NSCLC and RET fusions (2022) https://www.ejcancer.com/article/S0959-8049(22)00871-1/fulltext
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Psicología Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre One in Two podcast - The basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles